SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Advanced Mammography (MAMO). What's the potential ?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Burkhard Brinkmann who wrote (2)10/3/1996 7:36:00 PM
From: Shannon Squyres   of 24
 
Further info regarding MAMO: Their Aurora unit is the on ly MR scanning system out there. MRI is widely accepted as the most credible diagnostic methodology and Aurora makes MRI work for breast scanning -- due to efficiency and innovation in cost, size, and effectiveness. Stock price should be positively effected by
1) The cancellation of 2.7 mill of 4 mill MAMO shares held by their former parent, Advanced NMR. This is per their agreement and will occur by the end of November.
2) Any real buying in MAMO will cause a reaction due to the very small and tight float that MAMO has -- roughly 1.3 mill shares (a large portion of which are in very close hands).
3) MAMO has kept a low profile for quite a while but because they recently got their FDA approval and some funding last May they have embarked on a fairly aggressive campaign to bring MAMO to the financial community. We are starting to see the effect -- New market makers, bigger volume, frequent news releases. They will be noticed by lots of market movers, brokers, investors and newsletters etc.

Best to you,

SS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext